USFDA inspections gather pace; Indian pharma companies equipped to handle disruptions
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
The company is one of the most profitable companies manufacturing speciality chemicals in India
Cipla and Ethris partner for the development of mRNA-based therapies
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated